Meningitis B Vaccine – Bexsero

£125.00

Key Information About Bexsero:

- Administration: It is a two-dose vaccine, usually administered in the upper arm or thigh.
- Target Population: Approved for all age groups, starting from 2 months of age, with dosages tailored for infants, children, adolescents, and adults.
- Side Effects:
  Common side effects in children include fever, tenderness at the injection site, irritability, and decreased appetite. Adults may experience pain at the injection site, headache, or muscle aches.

Effectiveness: Studies show a 75% reduction in MenB infections in vaccinated groups. It works by inducing an immune response against the bacteria, with high bactericidal activity seen in trials.
GSK.CO.UK +5

Usage and Safety Precautions:

Safety: Bexsero is not recommended if the individual is allergic to any of its components.
Fever Management: While the vaccine can be given to children who are slightly unwell, it is generally recommended to wait if the child has a high fever.
Storage: The vaccine should be stored in a refrigerator (2°C–8°C) and not be frozen.
Appearance: The vaccine may have a fine, off-white deposit in the syringe, which should be shaken to form a homogeneous suspension before use.
GSK.CO.UK +2

Disclaimer: Always consult a healthcare professional regarding vaccinations, particularly for children, to understand the risks and benefits.

Product Description

Bexsero is a vaccine that protects against meningococcal group B (MenB) bacteria, which causes serious illnesses like meningitis and septicaemia. Approved in the EU and used in the UK since 2015, it is approved for individuals from 2 months of age and older, significantly reducing MenB infections and potentially offering protection against gonorrhoea.

This requires 2 shots

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Meningitis B Vaccine – Bexsero

Product Description

Reviews

BOOKING IS EASY

ONLINE HASSLE FREE APPOINTMENT BOOKING